Download PDF |

Jubilant Biosys Limited, based in Bangalore, an integrated Drug Discovery and Development solution provider, a subsidiary of Jubilant Organosys Ltd, headquartered in Noida, announced today that it has entered into a co-marketing agreement to provide screening solutions, with DiscoveRx Corporation (Fermont, USA), a premier provider of innovative cell based assay solutions for GPCR, Kinases, NHR and Proteases.

This agreement allows Jubilant access to DiscoveRx PathHunterTM and cAMPHunterTM cell lines and proprietary EFC chemiluminescent detection technology to perform screening on behalf of Jubilant's customers. The agreement also enables DiscoveRx to expand its platform technology to offer screening solutions from India.